An Investigation of Aspects Affecting Availability and the Health-economical Consequences of Shortages ofVancomycin and Piperacillin/Tazobactam

An Investigation of Aspects Affecting Availability and the Health-economical Consequences of Shortages ofVancomycin and Piperacillin/Tazobactam

This thesis investigates the supply chain of Vancomycin and Piperacillin/Tazobactam in order to understand why the two antibiotics have been exposed to back orders during recent years in Sweden. The health economical consequences due to these back orders of the two antibiotics was also examined. The...

Full description

Bibliographic Details
Main Authors:	Cederwall, Ida, Molin, Lina, Faghihi, Laura, Ali Mohsen, Lobna, Yekerusta, Ramon
Format:	Others
Language:	English
Published:	Uppsala universitet, Institutionen för materialvetenskap 2020
Subjects:	Shortages Vancomycin Piperacillin/Tazobactam Health-economical consequences supply chains Natural Sciences Naturvetenskap
Online Access:	http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-415529

Similar Items

Acute kidney injury associated with concomitant use of vancomycin with piperacillin-tazobactam: a focused review and meta-analysis
by: Hatice Duygu Bas, et al.
Published: (2016-06-01)

Galactomannan detection from piperacillin-tazobactam brands available in the Brazilian market
by: Melissa Orzechowski Xavier, et al.

Piperacillin/Tazobactam-Induced Neutropenia: A Case Report
by: Hayati DEMİRASLAN, et al.
Published: (2012-03-01)

Evaluation of Implementation of Extended-Infusion Piperacillin-Tazobactam at an Academic Medical Center
by: Radosevich, John, et al.
Published: (2011)

ACUTE KIDNEY INJURY IN PATIENTS TREATED WITH VANCOMYCIN AND PIPERACILLIN-TAZOBACTAM: A RETROSPECTIVE COHORT ANALYSIS
by: Rutter, Wilbur Cliff
Published: (2016)

A Case of DRESS Syndrome Associated with Piperacillin-Tazobactam Treatment and Literature Review
by: Seven ULUDOKUMACI, et al.
Published: (2012-12-01)

Similar Piperacillin/Tazobactam Target Attainment in Obese versus Nonobese Patients despite Differences in Interstitial Tissue Fluid Pharmacokinetics
by: David Busse, et al.
Published: (2021-08-01)

Risk factors of nosocomial infections caused by piperacillin-tazobactam resistant Pseudomonas aeruginosa
by: Đorđević Zorana, et al.
Published: (2013-01-01)

Synthesis and evaluation of polymeric micelle containing piperacillin/tazobactam for enhanced antibacterial activity
by: Milani Morteza, et al.
Published: (2019-01-01)

Superinfection rate among the patients treated with carbapenem versus piperacillin/tazobactam: Retrospective observational study
by: Hessa Al Muqati, et al.
Published: (2021-03-01)

A meta-analysis of piperacillin/tazobactam versus cefepime treatment in cancer patients with febrile neutropenia
by: Zhang Weidong, et al.
Published: (2016-12-01)

The potential of meropenem and piperacillin-tazobactam combination to Acinetobacter spp clinical isolates in vitro
by: Alindya Diani, et al.
Published: (2020-02-01)

Cefuroxime compared to piperacillin/tazobactam as empirical treatment of Escherichia coli bacteremia in a low Extended-spectrum beta-lactamase (ESBL) prevalence cohort
by: Thønnings S, et al.
Published: (2019-05-01)

FT-IR/ATR Solid Film Formation: Qualitative and Quantitative Analysis of a Piperacillin-Tazobactam Formulation
by: Ioanna Chrisikou, et al.
Published: (2020-12-01)

Frequency of Acute Kidney Injury in Patient Receiving Piperacillin - Tazobactam: A Hospital-based Study from Qatar
by: Fahmi Yousef Khan, et al.
Published: (2021-07-01)

Intravitreal piperacillin-tazobactam in endophthalmitis caused by Mycobacterium abscessus in silico ne-filled eye: A case report
by: G Suganeswari, et al.
Published: (2020-01-01)

Efficacy of two-time prophylactic intravenous administration of tazobactam/piperacillin for transrectal ultrasound-guided needle biopsy of the prostate
by: Hiroaki Iwamoto, et al.
Published: (2015-09-01)

Evaluating the appropriateness of carbapenem and piperacillin-tazobactam prescribing in a tertiary care hospital in Saudi Arabia
by: Nada A Alsaleh, et al.
Published: (2020-11-01)

Pharmacokinetics and outcome of tazobactam/piperacillin in Japanese patients undergoing low-flow continuous renal replacement therapy: dosage considerations
by: Kohama H, et al.
Published: (2017-02-01)

Bestimmung der in vitro Aktivität von Clindamycin, Imipenem, Metronidazol und Piperacillin/Tazobactam gegenüber sensiblen und resistenten Bacteroides fragilis Stämmen mittels Absterbekinetik
by: Funke, Matthias
Published: (2014)

Randomized controlled trial of piperacillin-tazobactam, cefepime and ertapenem for the treatment of urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli
by: Yu Bin Seo, et al.
Published: (2017-06-01)

Population Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Simulation of Piperacillin/Tazobactam for Dosing Optimization in Late Elderly Patients with Pneumonia
by: Noriyuki Ishihara, et al.
Published: (2020-03-01)

Cost-effectiveness of ceftolozane/tazobactam compared with piperacillin/tazobactam as empiric therapy based on the in-vitro surveillance of bacterial isolates in the United States for the treatment of complicated urinary tract infections
by: Teresa L Kauf, et al.
Published: (2017-04-01)

Higher incidence of acute kidney injury in patients treated with piperacillin/tazobactam than in patients treated with cefepime: a single-center retrospective cohort study
by: Shota Kadomura, et al.
Published: (2019-06-01)

Selection of piperacillin/tazobactam infusion mode guided by SOFA score in cancer patients with hospital-acquired pneumonia: a randomized controlled study
by: Lyu Y, et al.
Published: (2017-12-01)

Cost-effectiveness of ceftolozane/tazobactam plus metronidazole versus piperacillin/tazobactam as initial empiric therapy for the treatment of complicated intra-abdominal infections based on pathogen distributions drawn from national surveillance data in the United States
by: Vimalanand S. Prabhu, et al.
Published: (2017-10-01)

Comparison of the Effectiveness of Piperacillin-Tazobactam and Carbapenems in Nosocomial Infections with Extended-Spectrum Beta-lactamase-Producing Escherichia coli and Klebsiella pneumoniae
by: Müge AYHAN, et al.
Published: (2020-12-01)

Prospective evaluating the appropriate use of piperacillin /tazobactam in cardiac center of a tertiary care hospital
by: Sanaa Saeed Mekdad, et al.
Published: (2020-05-01)

Population Pharmacokinetics of Piperacillin in Non-Critically Ill Patients with Bacteremia Caused by Enterobacteriaceae
by: Vicente Merino-Bohórquez, et al.
Published: (2021-03-01)

Piperacillin/tazobactam-resistant, cephalosporin-susceptible Escherichia coli bloodstream infections are driven by multiple acquisition of resistance across diverse sequence types
by: Adams, E.R, et al.
Published: (2022)

Integrated Genome-Wide Analysis of an Isogenic Pair of <i>Pseudomonas aeruginosa</i> Clinical Isolates with Differential Antimicrobial Resistance to Ceftolozane/Tazobactam, Ceftazidime/Avibactam, and Piperacillin/Tazobactam
by: Weihua Huang, et al.
Published: (2020-02-01)

Utilizing the Patient Care Process to Minimize the Risk of Vancomycin-Associated Nephrotoxicity
by: Ashley R. Selby, et al.
Published: (2019-06-01)

Early Treatment Outcomes for Bloodstream Infections Caused by Potential AmpC Beta-Lactamase-Producing Enterobacterales with Focus on Piperacillin/Tazobactam: A Retrospective Cohort Study
by: Lena Herrmann, et al.
Published: (2021-06-01)

USING MACHINE LEARNING TO PREDICT ACUTE KIDNEY INJURIES AMONG PATIENTS TREATED WITH EMPIRIC ANTIBIOTICS
by: Rutter, Wilbur Cliff, IV
Published: (2018)

Concerning Nephrotoxicity of Top Guns: Concomitant Pippercillintazobactam and Vancomycin with Vancomycin Alone During Treatment of Critically Ill Patients
by: Sadaf Sheikh, et al.
Published: (2020-03-01)

Risk Factors of Death in Bloodstream Infections Caused by AmpC β-Lactamase-Producing Enterobacterales in Patients with Neoplasia
by: Cunha Ferreira T, et al.
Published: (2021-08-01)

Long-Term Stability Comparison between an Original and a Generic Version of Piperacillin/Tazobactam in Dextrose 5 % Infusion Polyolefin Bags at 5 ± 3 °C after Microwave Freeze-Thaw Treatment
by: Huvelle Sophie, et al.
Published: (2018-08-01)

Fosfomycin Resistance in <i>Escherichia coli</i> Isolates from South Korea and <i>in vitro</i> Activity of Fosfomycin Alone and in Combination with Other Antibiotics
by: Hyeri Seok, et al.
Published: (2020-03-01)

First UK case report of a patient with Pseudomonas mendocina bacteraemia
by: Natasha Greenough, et al.
Published: (2021-04-01)

Increased dosing regimens of piperacillin-tazobactam are needed to avoid subtherapeutic exposure in critically ill patients with augmented renal clearance
by: Thibaud Besnard, et al.
Published: (2019-01-01)